A double blind pilot study testing the effectiveness of Biotene mouthwash versus Normal Saline mouthwash to reduce the symptoms associated with mucositis in high dose chemotherapy patients.
- Conditions
- Cancer -Oral MucositisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12605000057684
- Lead Sponsor
- Auspharm Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 24
1. Diagnosed with acute leukaemia, high grade lymphoma, or any other disease that requires high dose chemotherapy and patients receiving an autogenic stem cell transplant 2. In patient of the study hospital and over the age of 18 years 3. Able to read and understand English 4. Agrees to use no other mouthwashes at time of inclusion into study 5. Agrees to participate in an RCT.
1. Patients receiving radiation treatment to head or neck 2. Patients who have a psychiatric history or mental/physical impairment that would hinder the individual to comply with the intervention.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.